Quest Diagnostics Incorporated (DGX) Earnings History
Earnings Pressure30 years of earnings data (1996–2025) · 5-year EPS trend is negative
Loading earnings history...
Quest Diagnostics Incorporated (DGX) Earnings Overview
As of June 22, 2026, Quest Diagnostics Incorporated (DGX) reported trailing twelve-month net income of $1.02B, reflecting +13.8% year-over-year growth. The company earned $9.14 per diluted share over the past four quarters, with a net profit margin of 9.0%.
Looking at the long-term picture, DGX's 5-year EPS compound annual growth rate (CAGR) stands at -3.6%, signaling declining earnings. The company achieved its highest annual net income of $2.00B in fiscal 2021.
Quest Diagnostics Incorporated maintains positive profitability with a gross margin of 31.9%, operating margin of 14.5%, and net margin of 9.0%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including LH ($942M net income, 6.3% margin), SLNO ($96M net income, 11.0% margin), EXAS (-$208M net income, -6.4% margin), DGX has outperformed on profitability metrics. Compare DGX vs LH →
DGX Earnings vs Peers
Earnings metrics vs comparable public companies
DGX Historical Earnings Data (1996–2025)
30 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $992M | +13.9% | $1.60B | $8.75 | 9.0% | 14.5% |
| 2024 | $871M | +2.0% | $1.35B | $7.69 | 8.8% | 13.6% |
| 2023 | $854M | -9.7% | $1.26B | $7.52 | 9.2% | 13.6% |
| 2022 | $946M | -52.6% | $1.43B | $7.98 | 9.6% | 14.4% |
| 2021 | $2.00B | +39.4% | $2.38B | $15.53 | 18.5% | 22.1% |
| 2020 | $1.43B | +66.8% | $1.97B | $10.52 | 15.2% | 20.9% |
| 2019 | $858M | +16.6% | $1.23B | $6.29 | 11.1% | 15.9% |
| 2018 | $736M | -4.7% | $1.10B | $5.29 | 9.8% | 14.6% |
| 2017 | $772M | +19.7% | $1.17B | $5.50 | 10.0% | 15.1% |
| 2016 | $645M | -9.0% | $1.28B | $4.51 | 8.6% | 17.0% |
| 2015 | $709M | +27.5% | $1.40B | $4.87 | 9.5% | 18.7% |
| 2014 | $556M | -34.5% | $983M | $3.81 | 7.5% | 13.2% |
| 2013 | $849M | +52.8% | $1.48B | $5.54 | 11.9% | 20.6% |
| 2012 | $556M | +18.1% | $1.20B | $3.46 | 7.5% | 16.3% |
| 2011 | $471M | -34.7% | $995M | $2.92 | 6.3% | 13.2% |
| 2010 | $721M | -1.1% | $1.30B | $4.05 | 9.8% | 17.6% |
| 2009 | $729M | +25.4% | $1.36B | $3.87 | 9.8% | 18.2% |
| 2008 | $582M | +71.1% | $1.22B | $2.97 | 8.0% | 16.9% |
| 2007 | $340M | -42.0% | $1.09B | $1.74 | 5.1% | 16.3% |
| 2006 | $586M | +7.3% | $1.13B | $2.94 | 9.4% | 18.0% |
| 2005 | $546M | +9.4% | $968M | $2.66 | 9.9% | 17.6% |
| 2004 | $499M | +14.3% | $901M | $2.35 | 9.7% | 17.6% |
| 2003 | $437M | +35.6% | $795M | $2.02 | 9.2% | 16.8% |
| 2002 | $322M | +98.5% | $592M | $1.62 | 7.8% | 14.4% |
| 2001 | $162M | +59.0% | $411M | $0.83 | 4.5% | 11.3% |
| 2000 | $102M | +3101.5% | $318M | $0.54 | 3.0% | 9.3% |
| 1999 | -$3M | -112.6% | $152M | $-0.03 | -0.2% | 6.9% |
| 1998 | $27M | +220.6% | $94M | $0.22 | 1.8% | 6.5% |
| 1997 | -$22M | +96.4% | $75M | $-0.19 | -1.5% | 4.9% |
| 1996 | -$626M | - | -$601M | $-5.33 | -38.7% | -37.2% |
Download Data
Export DGX earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into DGX consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
30+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
DGX — Frequently Asked Questions
Quick answers to the most common questions about buying DGX stock.
What is DGX earnings per share (EPS)?
DGX trailing twelve-month (TTM) diluted EPS is $9.14, reflecting +13.8% year-over-year growth. The 5-year EPS CAGR is -3.6%. Complete EPS history from 1996 to 2025 is available in the table on this page.
What is Quest Diagnostics Incorporated's net income?
Quest Diagnostics Incorporated (DGX) trailing twelve-month net income is $1.0B as of 2025. Earnings grew +13.8% year-over-year. Quest Diagnostics Incorporated has been profitable for 26 consecutive years.
Is DGX profitable?
Yes, DGX is profitable with a TTM net income of $1.0B and a net profit margin of +9.0%. Quest Diagnostics Incorporated has generated profits for 26 consecutive years.
What is DGX's earnings growth rate?
DGX compound annual EPS growth rates (CAGR): 1-Year: +13.8%, 3-Year: +3.1%, 5-Year: -3.6%, 10-Year: +6.0%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1996 to 2025.
What are DGX's profit margins?
Quest Diagnostics Incorporated net profit margin is +9.0%, operating margin is +14.5%, and gross margin is +31.9%. Margins are within a typical range for the sector. Return on Equity is +14.0%.
Is DGX growing earnings?
DGX is growing earnings steadily. YoY EPS growth of +13.8% is consistent with the 5-year CAGR of -3.6%. TTM net income is $1.0B.
What was DGX's best earnings year?
Quest Diagnostics Incorporated's highest annual net income on record is $2.0B, achieved in fiscal year 2021. Earnings history on this page spans 1996 to 2025 and includes all annual and quarterly figures.
What were DGX's earnings last quarter?
DGX's most recent reported quarter was Q1 2026. Net income was $252M with diluted EPS of $2.24. For a full breakdown of all quarters, see the quarterly earnings table on this page.